Premature separation of placenta with afibrinogenemia, second trimester digital illustration

Premature separation of placenta with afibrinogenemia, second trimester Save


ICD-10 code: O45.012

Disease category: O45.01: Premature separation of placenta with afibrinogenemia

Premature Separation of Placenta with Afibrinogenemia in the Second Trimester

Premature separation of placenta, also known as placental abruption, is a serious condition that can occur during pregnancy. When this condition is combined with afibrinogenemia, a rare blood clotting disorder, it can pose significant risks to both the mother and the developing fetus. This article provides an overview of premature separation of placenta with afibrinogenemia during the second trimester of pregnancy.

Causes:

  1. Genetic factors: Afibrinogenemia is an inherited disorder that affects blood clotting. It is caused by mutations in the genes responsible for producing fibrinogen, a protein necessary for blood clot formation.
  2. Trauma: Any physical injury to the abdomen, such as a fall or a motor vehicle accident, can increase the risk of placental abruption in women with afibrinogenemia.

Symptoms:

  • Vaginal bleeding: One of the most common symptoms of placental abruption is vaginal bleeding, which may vary in severity.
  • Abdominal pain: Women experiencing premature separation of placenta often report severe abdominal pain that is persistent and may be accompanied by uterine contractions.
  • Uterine tenderness: The uterus may feel tender or painful to the touch.

Risks and Complications:

  • Maternal complications: Premature separation of placenta with afibrinogenemia can lead to severe maternal hemorrhage, shock, and organ failure.
  • Fetal complications: The condition poses a significant risk to the fetus, including fetal distress, growth restriction, and even stillbirth.

Diagnosis:

  1. Physical examination: A thorough physical examination can help identify signs of placental abruption, such as uterine tenderness and abnormal fetal heart rate.
  2. Ultrasound: An ultrasound scan can help determine the extent of placental separation and evaluate the well-being of the fetus.

In conclusion, premature separation of placenta with afibrinogenemia in the second trimester can have serious consequences for both the mother and the developing fetus. It is crucial for pregnant women with this condition to receive appropriate medical care and monitoring to minimize the risks and complications associated with placental abruption. If you suspect any symptoms related to this condition, consult your healthcare provider immediately for proper diagnosis and guidance.

Treatment of Premature separation of placenta with afibrinogenemia, second trimester:

Treatment Options for Premature Separation of Placenta with Afibrinogenemia in the Second Trimester

Premature separation of placenta with afibrinogenemia in the second trimester is a serious condition that requires immediate medical attention. It can lead to complications for both the mother and the baby. Fortunately, there are treatment options available to manage this condition a...

To see full information about treatment please Sign up or Log in